U.S. FDA Advisers Recommend Approval of Pfizer COVID-19 Vaccine for Kids Aged 5 to 11
A panel of independent advisers for the United States Food and Drug Administration (FDA) recommended on Oct. 26 the Pfizer-BioNTech COVID-19 vaccine for children aged five to 11. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 17 to …